METTL3 and systemic lupus erythematosus: Specifically, decreased METTL3 levels in SLE CD4+ T cells lead to overactivation and disrupt the balance of effector T cell differentiation, contributing to elevated Th1 and Th17 subsets and reduced regulatory T (Treg) cell differentiation in mouse models [218].